Natco Pharma Shares Slide 15 as Q4 Results Disappoint Net Profit Drops 34 AJG Q1 2026 Earnings Modest EPS Miss Amid Steady Operations Plus500 Reports 11 Quarterly Revenue Growth Reaffirms FullYear Guidance